The research in this field has remained constant in the last 10 years, as the number of publications on PubMed, Figure 2, proves
Who Should Avoid It Active malignancy (GH may promote tumor growth) Diabetic retinopathy Pregnancy or breastfeeding Pituitary disorders Hypersensitivity to components Stop Right Away If You Notice Severe injection site reactions Significant swelling or edema Signs of glucose dysregulation Severe joint pain Allergic reactions Milder Signs to Watch For How Long Should a Tesamorelin/Ipamorelin Blend (Tesamorelin, Ipamorelin) Cycle Last
Regulatory changes : The FDA has been tightening rules around compounding, especially for GLP-1 medications, so availability can shift quickly
Used in Europe and Asia for stroke and dementia treatment
Medication Type: Zepbound vial, Zepbound, Wegovy, and Saxenda
377 Indicators of iron metabolism might be useful for assessing disease severity and monitoring clinical efficacy in MG patients